Concepedia

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Antonio Uccelli, Alice Laroni, Rehiana Ali, Mario Alberto Battaglia, Morten Blinkenberg, Lou Brundin, Michel Clanet, Óscar Fernández, James Marriott, Paolo A. Muraro,

The Lancet Neurology · 2021 · 109 citations · 31 references

DOI

Concepts

References

31

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3.1K citations · Full text

, , +17

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball et al. · The Lancet · 2008 · 2.7K citations

, , +11

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

, , +15

Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.

A. J. Friedenstein, K. V. Petrakova, Alexandra Ivanovna Kurolesova et al. · PubMed · 1968 · 1.9K citations

, , +16

Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6

Ryang Hwa Lee, Min Jeong Seo, Daniel J. Kota et al. · Cell stem cell · 2009 · 1.9K citations · Full text

, , +12